Inhibition of host kinase activity altered by the LMP2A signalosome - A therapeutic target for Epstein-Barr virus latency and associated disease

Lori Cooper, Richard Longnecker*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of host kinase activity altered by the LMP2A signalosome - A therapeutic target for Epstein-Barr virus latency and associated disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology